SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-17-000049
Filing Date
2017-06-05
Accepted
2017-06-05 17:25:38
Documents
1
Period of Report
2017-06-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4035
  Complete submission text file 0001250853-17-000049.txt   5660
Mailing Address C/O AYER CAPITAL MANAGEMENT, LP 230 CALIFORNIA ST, SUITE 600 SAN FRANCISCO CA 94111
Business Address
Venkatesan Jay (Reporting) CIK: 0001413350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36860 | Film No.: 17892220

Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
Lion Biotechnologies, Inc. (Issuer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)